scholarly article | Q13442814 |
P50 | author | Eric Boersma | Q57288054 |
P2093 | author name string | Annemien E van den Bosch | |
Jolien W Roos-Hesselink | |||
Judith A A E Cuypers | |||
Maarten Witsenburg | |||
Jackie S McGhie | |||
Petra Opić | |||
Titia P E Ruys | |||
Jannet A Eindhoven | |||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1203-1212 | |
P577 | publication date | 2013-07-31 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease | |
P478 | volume | 62 |
Q38968650 | Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients |
Q43655956 | Association between N-terminal pro-brain natriuretic peptide and quality of life in adult patients with congenital heart disease |
Q37307245 | B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle. |
Q38324210 | BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? |
Q38603770 | Cardiac biomarkers in children with congenital heart disease |
Q36073360 | Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis |
Q38672312 | Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P. |
Q38825516 | Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease |
Q39196071 | Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank |
Q92732020 | Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle |
Q44030613 | Heart failure in adult congenital heart disease |
Q39005911 | Heart transplantation in adult congenital heart disease |
Q40850072 | Matrix metalloproteinases as candidate biomarkers in adults with congenital heart disease |
Q54445625 | N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. |
Q37341787 | NT-proBNP and exercise capacity in adult patients with congenital heart disease and a prosthetic valve: a multicentre PROSTAVA study |
Q39165884 | NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study. |
Q48263163 | NT-proBNP predicts mortality in adults with transposition of the great arteries late after Mustard or Senning correction. |
Q55439640 | Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease. |
Q48491567 | Quantitative assessment of systolic right ventricular function using myocardial deformation in patients with a systemic right ventricle |
Q35785968 | Relation between E/e' ratio and NT-proBNP levels in elderly patients with symptomatic severe aortic stenosis |
Q48233248 | Right ventricular function and N-terminal pro-brain natriuretic peptide levels in adult patients with simple dextro-transposition of the great arteries |
Q48349829 | The change in NT-pro-BNP and post-PTMC echocardiography parameters in patients with mitral stenosis. A pilot study |
Q38182858 | The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. |
Q37023891 | Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology |
Q35939968 | Usefulness of insulin like growth factor 1 as a marker of heart failure in children and young adults after the Fontan palliation procedure |
Q96133576 | Utility of biomarkers in adult Fontan patients with decompensated heart failure |
Search more.